LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD Market Closed
Market Cap: 45.8m USD

LAVA Therapeutics NV
Depreciation & Amortization

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

LAVA Therapeutics NV
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Depreciation & Amortization
$467k
CAGR 3-Years
-6%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Depreciation & Amortization
$15.6m
CAGR 3-Years
-6%
CAGR 5-Years
26%
CAGR 10-Years
44%
ProQR Therapeutics NV
NASDAQ:PRQR
Depreciation & Amortization
€2.7m
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
21%
Uniqure NV
NASDAQ:QURE
Depreciation & Amortization
$16.1m
CAGR 3-Years
26%
CAGR 5-Years
10%
CAGR 10-Years
13%
argenx SE
XBRU:ARGX
Depreciation & Amortization
$17.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Depreciation & Amortization
$2.4m
CAGR 3-Years
23%
CAGR 5-Years
12%
CAGR 10-Years
27%
No Stocks Found

LAVA Therapeutics NV
Glance View

Market Cap
45.8m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
2.52 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is LAVA Therapeutics NV's Depreciation & Amortization?
Depreciation & Amortization
467k USD

Based on the financial report for Dec 31, 2024, LAVA Therapeutics NV's Depreciation & Amortization amounts to 467k USD.

What is LAVA Therapeutics NV's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
12%

Over the last year, the Depreciation & Amortization growth was -24%. The average annual Depreciation & Amortization growth rates for LAVA Therapeutics NV have been -6% over the past three years , 12% over the past five years .

Back to Top